Source - RNS
RNS Number : 8436Y
Unilever PLC
13 May 2019
 

 

Unilever completes share purchase programme

 

 

13 May 2019

 

London/Rotterdam - Unilever PLC and Unilever N.V. today confirm the successful completion of the programme to purchase shares up to an aggregate market value equivalent of €165 million announced on 29 April 2019.  Under this programme, 995,000 Unilever PLC shares and 1,787,000 Unilever N.V. shares were purchased.

 

In addition, 81,000 American Depositary Shares of Unilever PLC and 891,000 New York Registry Shares of Unilever N.V. were purchased.

 

 

Unilever contacts

 

Unilever PLC

 

Unilever House                                  

100 Victoria Embankment                  

London EC4Y 0DY
United Kingdom          

 

+44 (0) 207 822 5252                         

[email protected]     

 

Clare Cavana                                             

 

+44 (0) 793 448 3444 [email protected]

 

 

Unilever NV

 

Weena 455

3013 AL Rotterdam

www.unilever.nl

 

+31 (0) 10 217 4000

[email protected]

 

Fleur van Bruggen

 

+31 (0) 217 4844

[email protected]

 

 

Safe Harbour:

 

This announcement may contain forward-looking statements, including 'forward-looking statements' within the meaning of the United States Private Securities Litigation Reform Act of 1995. Words such as 'will', 'aim', 'expects', 'anticipates', 'intends', 'looks', 'believes', 'vision', or the negative of these terms and other similar expressions of future performance or results, and their negatives, are intended to identify such forward-looking statements. These forward-looking statements are based upon current expectations and assumptions regarding anticipated developments and other factors affecting the Unilever Group (the 'Group'). They are not historical facts, nor are they guarantees of future performance.

 

Because these forward-looking statements involve risks and uncertainties, there are important factors that could cause actual results to differ materially from those expressed or implied by these forward-looking statements. Among other risks and uncertainties, the material or principal factors which could cause actual results to differ materially are: Unilever's global brands not meeting consumer preferences; Unilever's ability to innovate and remain competitive; Unilever's investment choices in its portfolio management; inability to find sustainable solutions to support long-term growth including to plastic packaging; the effect of climate change on Unilever's business; significant changes or deterioration in customer relationships; the recruitment and retention of talented employees; disruptions in our supply chain and distribution; increases or volatility in the cost of raw materials and commodities; the production of safe and high quality products; secure and reliable IT infrastructure; execution of acquisitions, divestitures and business transformation projects; economic, social and political risks and natural disasters; financial risks; failure to meet high and ethical standards; and managing regulatory, tax and legal matters.

 

These forward-looking statements speak only as of the date of this announcement. Except as required by any applicable law or regulation, the Group expressly disclaims any obligation or undertaking to release publicly any updates or revisions to any forward-looking statements contained herein to reflect any change in the Group's expectations with regard thereto or any change in events, conditions or circumstances on which any such statement is based.

 

Further details of potential risks and uncertainties affecting the Group are described in the Group's filings with the London Stock Exchange, Euronext Amsterdam and the US Securities and Exchange Commission, including in the Annual Report on Form 20-F 2018 and the Unilever Annual Report and Accounts 2018.


This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.
 
END
 
 
MSCFXLFFKEFFBBZ